{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:23:06Z","timestamp":1792819386070,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T00:00:00Z","timestamp":1535932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T00:00:00Z","timestamp":1535932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2019,2,7]]},"DOI":"10.1038\/s41388-018-0485-8","type":"journal-article","created":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T10:03:36Z","timestamp":1535969016000},"page":"868-880","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["HMGB1 correlates with angiogenesis and poor prognosis of perihilar cholangiocarcinoma via elevating VEGFR2 of vessel endothelium"],"prefix":"10.1038","volume":"38","author":[{"given":"Yun-Fei","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeng-Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Lei","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Da","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong-Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,3]]},"reference":[{"key":"485_CR1","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","volume":"383","author":"N Razumilava","year":"2014","unstructured":"Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet. 2014;383:2168\u201379.","journal-title":"Lancet"},{"key":"485_CR2","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","volume":"145","author":"S Rizvi","year":"2013","unstructured":"Rizvi S, Gores GJ. Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology. 2013;145:1215\u201329.","journal-title":"Gastroenterology"},{"key":"485_CR3","first-page":"208","volume":"14","author":"KD Lillemoe","year":"2003","unstructured":"Lillemoe KD. Tumors of the gallbladder, bile ducts, and ampulla. Semin Gastrointest Dis. 2003;14:208\u201321.","journal-title":"Semin Gastrointest Dis"},{"key":"485_CR4","first-page":"95","volume":"15","author":"S Rizvi","year":"2017","unstructured":"Rizvi S, Khan SA, Hallemeier CL, Kelley RK, Gores GJ. Cholangiocarcinoma - evolving concepts and therapeutic strategies. Nat Rev Clin Oncol. 2017;15:95\u2013111.","journal-title":"Nat Rev Clin Oncol"},{"key":"485_CR5","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/01.sla.0000251366.62632.d3","volume":"245","author":"ML DeOliveira","year":"2007","unstructured":"DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD, et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007;245:755\u201362.","journal-title":"Ann Surg"},{"key":"485_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bbagrm.2009.09.008","volume":"1799","author":"M Stros","year":"2010","unstructured":"Stros M. HMGB proteins: interactions with DNA and chromatin. Biochim Biophys Acta. 2010;1799:101\u201313.","journal-title":"Biochim Biophys Acta"},{"key":"485_CR7","doi-asserted-by":"publisher","first-page":"451","DOI":"10.4161\/auto.23691","volume":"9","author":"Q Zhang","year":"2013","unstructured":"Zhang Q, Kang R, Zeh HJ 3rd, Lotze MT, Tang D. DAMPs and autophagy: cellular adaptation to injury and unscheduled cell death. Autophagy. 2013;9:451\u20138.","journal-title":"Autophagy"},{"key":"485_CR8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nature18317","volume":"535","author":"DC Avgousti","year":"2016","unstructured":"Avgousti DC, Herrmann C, Kulej K, Pancholi NJ, Sekulic N, Petrescu J, et al. A core viral protein binds host nucleosomes to sequester immune danger signals. Nature. 2016;535:173\u20137.","journal-title":"Nature"},{"key":"485_CR9","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1128\/MCB.23.8.2991-2998.2003","volume":"23","author":"I Poser","year":"2003","unstructured":"Poser I, Golob M, Buettner R, Bosserhoff AK. Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype. Mol Cell Biol. 2003;23:2991\u20138.","journal-title":"Mol Cell Biol"},{"key":"485_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/path.1031","volume":"196","author":"H Kuniyasu","year":"2002","unstructured":"Kuniyasu H, Oue N, Wakikawa A, Shigeishi H, Matsutani N, Kuraoka K, et al. Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer. J Pathol. 2002;196:163\u201370.","journal-title":"J Pathol"},{"key":"485_CR11","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S0002-9440(10)62296-1","volume":"166","author":"H Kuniyasu","year":"2005","unstructured":"Kuniyasu H, Yano S, Sasaki T, Sasahira T, Sone S, Ohmori H. Colon cancer cell-derived high mobility group 1\/amphoterin induces growth inhibition and apoptosis in macrophages. Am J Pathol. 2005;166:751\u201360.","journal-title":"Am J Pathol"},{"key":"485_CR12","doi-asserted-by":"publisher","first-page":"157103","DOI":"10.1155\/2013\/157103","volume":"2013","author":"M Gnanasekar","year":"2013","unstructured":"Gnanasekar M, Kalyanasundaram R, Zheng G, Chen A, Bosland MC, Kajdacsy-Balla A. HMGB1: a promising therapeutic target for prostate cancer. Prostate Cancer. 2013;2013:157103.","journal-title":"Prostate Cancer"},{"key":"485_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/path.2391","volume":"216","author":"D Wu","year":"2008","unstructured":"Wu D, Ding Y, Wang S, Zhang Q, Liu L. Increased expression of high mobility group box 1 (HMGB1) is associated with progression and poor prognosis in human nasopharyngeal carcinoma. J Pathol. 2008;216:167\u201375.","journal-title":"J Pathol"},{"key":"485_CR14","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.3748\/wjg.v21.i11.3256","volume":"21","author":"YF Xu","year":"2015","unstructured":"Xu YF, Ge FJ, Han B, Yang XQ, Su H, Zhao AC, et al. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma. World J Gastroenterol. 2015;21:3256\u201365.","journal-title":"World J Gastroenterol"},{"key":"485_CR15","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1053\/j.gastro.2013.01.001","volume":"144","author":"D Sia","year":"2013","unstructured":"Sia D, Hoshida Y, Villanueva A, Roayaie S, Ferrer J, Tabak B, et al. Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology. 2013;144:829\u201340.","journal-title":"Gastroenterology"},{"key":"485_CR16","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/sj.bjc.6604129","volume":"98","author":"D Yoshikawa","year":"2008","unstructured":"Yoshikawa D, Ojima H, Iwasaki M, Hiraoka N, Kosuge T, Kasai S, et al. Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma. Br J Cancer. 2008;98:418\u201325.","journal-title":"Br J Cancer"},{"key":"485_CR17","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bbrc.2014.02.050","volume":"446","author":"YF Xu","year":"2014","unstructured":"Xu YF, Yang XQ, Lu XF, Guo S, Liu Y, Iqbal M, et al. Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma. Biochem Biophys Res Commun. 2014;446:54\u201360.","journal-title":"Biochem Biophys Res Commun"},{"key":"485_CR18","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1158\/0008-5472.CAN-05-2217","volume":"66","author":"J Dixelius","year":"2006","unstructured":"Dixelius J, Olsson AK, Thulin A, Lee C, Johansson I, Claesson-Welsh L. Minimal active domain and mechanism of action of the angiogenesis inhibitor histidine-rich glycoprotein. Cancer Res. 2006;66:2089\u201397.","journal-title":"Cancer Res"},{"key":"485_CR19","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/onc.2012.49","volume":"32","author":"JR van Beijnum","year":"2013","unstructured":"van Beijnum JR, Nowak-Sliwinska P, van den Boezem E, Hautvast P, Buurman WA, Griffioen AW. Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1. Oncogene. 2013;32:363\u201374.","journal-title":"Oncogene"},{"issue":"Suppl 1","key":"485_CR20","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.2119\/molmed.2015.00087","volume":"21","author":"H Yang","year":"2015","unstructured":"Yang H, Wang H, Chavan SS, Andersson U. High mobility group box protein 1 (HMGB1): the prototypical endogenous danger molecule. Mol Med. 2015;21(Suppl 1):S6\u2013S12.","journal-title":"Mol Med"},{"key":"485_CR21","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1172\/JCI76887","volume":"125","author":"P Huebener","year":"2015","unstructured":"Huebener P, Pradere JP, Hernandez C, Gwak GY, Caviglia JM, Mu X, et al. The HMGB1\/RAGE axis triggers neutrophil-mediated injury amplification following necrosis. J Clin Invest. 2015;125:539\u201350.","journal-title":"J Clin Invest"},{"key":"485_CR22","doi-asserted-by":"publisher","first-page":"R362","DOI":"10.1152\/ajpregu.00184.2009","volume":"297","author":"R Yang","year":"2009","unstructured":"Yang R, Miki K, Oksala N, Nakao A, Lindgren L, Killeen ME, et al. Bile high-mobility group box 1 contributes to gut barrier dysfunction in experimental endotoxemia. Am J Physiol Regul Integr Comp Physiol. 2009;297:R362\u2013369.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"485_CR23","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1089\/ars.2010.3356","volume":"14","author":"D Tang","year":"2011","unstructured":"Tang D, Kang R, Zeh HJ 3rd, Lotze MT. High-mobility group box 1, oxidative stress, and disease. Antioxid Redox Signal. 2011;14:1315\u201335.","journal-title":"Antioxid Redox Signal"},{"key":"485_CR24","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/cr.2017.51","volume":"27","author":"R Kang","year":"2017","unstructured":"Kang R, Xie Y, Zhang Q, Hou W, Jiang Q, Zhu S, et al. Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer. Cell Res. 2017;27:916\u201332.","journal-title":"Cell Res"}],"updated-by":[{"DOI":"10.1038\/s41388-025-03514-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000}}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-018-0485-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-018-0485-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-018-0485-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T16:13:18Z","timestamp":1757088798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-018-0485-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,3]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,2,7]]}},"alternative-id":["485"],"URL":"https:\/\/doi.org\/10.1038\/s41388-018-0485-8","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41388-025-03514-w","asserted-by":"object"}]},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,3]]},"assertion":[{"value":"23 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: Following the publication of this article, the authors noted that the image of Figure 1C was mistakenly used. The authors confirm that this correction does not affect the scientific conclusions of this manuscript and apologize to the journal and readers for this mistake.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41388-025-03514-w","URL":"https:\/\/doi.org\/10.1038\/s41388-025-03514-w","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}